Compare · CAH vs HLF
CAH vs HLF
Side-by-side comparison of Cardinal Health Inc. (CAH) and Herbalife Ltd. (HLF): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CAH and HLF operate in Other Pharmaceuticals (Health Care), so they compete in similar markets.
- CAH is the larger of the two at $58.75B, about 38.5x HLF ($1.53B).
- CAH has been more active in the news (5 items in the past 4 weeks vs 2 for HLF).
- CAH has more recent analyst coverage (25 ratings vs 14 for HLF).
- Company
- Cardinal Health Inc.
- Herbalife Ltd.
- Price
- -
- -
- Market cap
- $58.75B
- $1.53B
- 1M return
- +12.23%
- -
- 1Y return
- +62.45%
- -
- Industry
- Other Pharmaceuticals
- Other Pharmaceuticals
- Exchange
- NYSE
- NYSE
- IPO
- 2004
- News (4w)
- 5
- 2
- Recent ratings
- 25
- 14
Cardinal Health Inc.
Cardinal Health, Inc. operates as an integrated healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and offers medication therapy management and patient outcomes services to hospitals, other healthcare providers, and payers, as well as provides pharmacy management services to hospitals. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. The segment also distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. Cardinal Health, Inc. was founded in 1979 and is headquartered in Dublin, Ohio.
Herbalife Ltd.
Herbalife Nutrition Ltd. offers nutrition solutions in North America, Mexico, South and Central America, Europe, the Middle East, Africa, and the Asia Pacific. The company provides products in the areas of weight management; targeted nutrition; energy, sports, and fitness; and outer nutrition. It offers weight management products, including meal replacement products, protein shakes, drink mixes, weight loss enhancers, and healthy snacks; targeted nutrition products, which include functional beverages, and dietary and nutritional supplements that contain herbs, vitamins, minerals, and other natural ingredients; outer nutrition products, such as facial skin, body, and hair care products; and energy, sports, and fitness products comprising N-R-G tea and energy drink products. The company also provides literature, promotional, and other materials that include start-up kits, sales tools, and educational materials. It offers its products through independent service providers and sales representatives, as well as through company-operated retail platforms. The company was formerly known as Herbalife Ltd. and changed its name to Herbalife Nutrition Ltd. in April 2018. Herbalife Nutrition Ltd. was founded in 1980 and is headquartered in Los Angeles, California.
Latest CAH
- Cardinal Health Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
- Cardinal Health Enters into Binding Letter of Intent to Extend Pharmaceutical Distribution Agreements with CVS Health
- Cardinal Health to Announce First-Quarter Results for Fiscal Year 2027 on November 5
- SEC Form DEF 14A filed by Cardinal Health Inc.
- SEC Form DEFA14A filed by Cardinal Health Inc.
- Chief Accounting Officer Scherer Mary C. sold $546,473 worth of shares (2,302 units at $237.39), decreasing direct ownership by 45% to 2,811 units (SEC Form 4)
- Chief Executive Officer Hollar Jason M. sold $29,375,516 worth of shares (124,529 units at $235.89), decreasing direct ownership by 40% to 190,603 units (SEC Form 4)
- CEO, GMPD Segment Mason Stephen M sold $8,274,117 worth of shares (35,000 units at $236.40), decreasing direct ownership by 66% to 18,061 units (SEC Form 4)
- CEO, PSS Segment Weitzman Deborah sold $1,731,524 worth of shares (7,354 units at $235.45), decreasing direct ownership by 9% to 77,901 units (SEC Form 4)
- Chief Financial Officer Alt Aaron E sold $9,926,140 worth of shares (42,000 units at $236.34), decreasing direct ownership by 67% to 20,495 units (SEC Form 4)
Latest HLF
- Herbalife to Participate in 1 on 1 Meetings at Maxim Growth Summit on October 14
- Herbalife to Announce Third Quarter 2026 Results on November 2
- Herbalife Announces $250 Million Share Repurchase Program
- Herbalife Reaffirms Third Quarter and Full Year 2026 Guidance
- Herbalife Ltd. filed SEC Form 8-K: Leadership Update
- Herbalife Announces Planned CEO Transition
- Herbalife to Participate in Fireside Chat at Barclays Global Consumer Conference on September 9
- Amendment: SEC Form SCHEDULE 13G/A filed by Herbalife Ltd.
- Herbalife to Present and Host 1x1 Investor Meetings at Midwest IDEAS Investor Conference on August 26
- Amendment: SEC Form SCHEDULE 13G/A filed by Herbalife Ltd.